Published in Lancet on August 29, 1992
Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction. CMAJ (1998) 1.16
Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use. Gut (1996) 0.87
Silent myocardial ischaemia in patients with proved coronary artery disease: a comparison of diabetic and non-diabetic patients. Postgrad Med J (2001) 0.87
Antiplatelet therapy--Part I. West J Med (1993) 0.84
Antiplatelet drugs in cardiological practice: established strategies and new developments. Vasc Health Risk Manag (2008) 0.84
The case for preoperative aspirin administration in patients undergoing elective CABG: is it open or closed? Ann Transl Med (2016) 0.75
Sudden cardiac death and the potential role of beta adrenoceptor-blocking drugs. Postgrad Med J (1994) 0.75
Cardiovascular diseases in Ghana within the context of globalization. Cardiovasc Diagn Ther (2016) 0.75
Gastro-duodenal injury associated with intake of 100-325mg aspirin daily. Postgrad Med J (1994) 0.75
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (1999) 4.36
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med (2000) 4.35
Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation (1996) 2.91
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial. J Thromb Haemost (2011) 2.87
Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol (2001) 2.87
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS. Eur Heart J (2004) 2.67
Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology (1986) 2.46
Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation (1997) 2.43
Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA (2001) 2.37
Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators. J Am Coll Cardiol (2001) 1.92
Early statin treatment following acute myocardial infarction and 1-year survival. JAMA (2001) 1.89
The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial: results with and without the end-point committee's final decision on end-points. Eur Heart J (1999) 1.72
Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med (2010) 1.71
Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register. J Intern Med (2009) 1.65
Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. Eur Heart J (1997) 1.65
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart (2008) 1.54
Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood (2000) 1.45
Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J Mol Biol (2000) 1.43
Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol (1995) 1.42
The combination of a continuous 12-lead ECG and troponin T; a valuable tool for risk stratification during the first 6 hours in patients with chest pain and a non-diagnostic ECG. Eur Heart J (2000) 1.40
Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization. Eur Heart J (2002) 1.39
Development of atopic disease and disturbed sleep in childhood and adolescence--a longitudinal population-based study. Clin Exp Allergy (2013) 1.39
Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease. FRISC study group. Fragmin during Instability in Coronary Artery Disease. Eur Heart J (1999) 1.39
The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease. Eur Heart J (1999) 1.39
[Coronary vessel surgery. Are early operations really superior to the more and more effective drug therapy?]. Lakartidningen (1994) 1.39
Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment. Eur Heart J (2002) 1.39
Continuous monitoring of irrigating fluid absorption during transurethral surgery. Anaesthesia (1995) 1.39
Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J (1999) 1.38
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol (1997) 1.37
Gamma-interferon-mediated down-regulation of electrolyte secretion by intestinal epithelial cells: a local immune mechanism? Scand J Immunol (1989) 1.35
Histological indications of a progressive snorers disease in an upper airway muscle. Am J Respir Crit Care Med (1998) 1.32
Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis. J Biol Chem (2000) 1.31
A twin study of autism symptoms in Sweden. Mol Psychiatry (2010) 1.22
Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell. Biochim Biophys Acta (1984) 1.21
Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology (1983) 1.18
Neurogenic effects on the palatopharyngeal muscle in patients with obstructive sleep apnoea: a muscle biopsy study. J Neurol Neurosurg Psychiatry (1992) 1.17
Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease. Eur Heart J (2003) 1.16
Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006-2009. Acta Psychiatr Scand (2012) 1.16
The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro. Scand J Gastroenterol Suppl (1985) 1.14
Plasma lipoproteins including high density lipoprotein subfractions during normal pregnancy. Obstet Gynecol (1985) 1.12
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant. J Med Microbiol (1996) 1.08
Behçet's disease and close contact with pigs. Acta Med Scand (1984) 1.05
Induction of a sheet polymer of tubulin by Zn2+. Exp Cell Res (1976) 1.05
Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome. Heart (2007) 1.04
FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease. Heart (2005) 1.04
Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1997) 1.03
The relationship between gastric acid secretion and gastric H+,K+-ATPase activity. J Biol Chem (1985) 1.03
Hypergastrinaemia produces trophic effects in stomach but not in pancreas and intestines. Regul Pept (1986) 1.03
Measurement of apolipoprotein E (apoE) in cerebrospinal fluid. Neurochem Res (2000) 1.03
Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol (2000) 1.01
Effects of pregabalin on visceral pain responses and colonic compliance in rats. Br J Pharmacol (2008) 1.01
A limited diagnostic investigation for obstructive sleep apnea syndrome. Oximetry and static charge sensitive bed. Chest (1990) 1.01
Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel. Horm Metab Res (1979) 1.00
The effects of orchiectomy, oestrogens and cyproterone-acetate on the antithrombin-III concentration in carcinoma of the prostate. Urol Res (1981) 1.00
The profilin--actin complex: further characterization of profilin and studies on the stability of the complex. J Muscle Res Cell Motil (1983) 1.00
Plasma lipoproteins during anti-androgen treatment by estrogens or orchidectomy in men with prostatic carcinoma. Horm Metab Res (1981) 1.00
Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo. Scand J Gastroenterol Suppl (1985) 1.00
Different heritabilities but shared etiological influences for parent, teacher and self-ratings of ADHD symptoms: an adolescent twin study. Psychol Med (2013) 0.99
Structure-activity relationship of omeprazole and analogues as Helicobacter pylori urease inhibitors. J Med Chem (1995) 0.99
Early assessment of patients with suspected acute myocardial infarction by biochemical monitoring and neural network analysis. Clin Chem (1997) 0.99
Cardiovascular risk factors and clinical presentation in acute coronary syndromes. Heart (2005) 0.99
Very early risk stratification by electrocardiogram at rest in men with suspected unstable coronary heart disease. The RISC Study Group. J Intern Med (1993) 0.98
The FRISC experience with troponin T. Use as decision tool and comparison with other prognostic markers. Eur Heart J (1998) 0.98
Risk of bacteraemia and mortality in patients with haematological malignancies. Clin Microbiol Infect (2006) 0.97
Offspring psychopathology following preconception, prenatal and postnatal maternal bereavement stress. Psychol Med (2013) 0.97
In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions. Antimicrob Agents Chemother (1996) 0.97
Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose tolerance. Eur J Endocrinol (1997) 0.96
Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion. Am J Physiol (1983) 0.96
Omeprazole and ranitidine, antisecretagogues with different modes of action, are equally effective in causing hyperplasia of enterochromaffin-like cells in rat stomach. Regul Pept (1989) 0.95
Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes. Data from the Euro Heart Survey ACS. Diabet Med (2005) 0.95
Nucleation of actin polymerization from profilactin. Opposite effects of different nuclei. Biochim Biophys Acta (1982) 0.95
Semitendinosus muscle in anterior cruciate ligament surgery: Morphology and function. Arthroscopy (2001) 0.94
Molecular cloning and characterization of starch-branching enzyme II from potato. Plant Mol Biol (1998) 0.94
Inhibition of gastric acid secretion by omeprazole and ranitidine. Effects on plasma gastrin and gastric histamine, histidine decarboxylase activity and ECL cell density in normal and antrectomized rats. Scand J Gastroenterol Suppl (1986) 0.94
Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase. Circulation (1998) 0.93
Development of nocturnal respiratory disturbance in untreated patients with obstructive sleep apnea syndrome. Chest (1993) 0.93
Revision total hip arthroplasty using third-generation cementing technique. J Arthroplasty (2000) 0.92
Plasma theophylline level and ventilatory function in chronic obstructive pulmonary disease during prolonged oral treatment with choline theophyllinate. Eur J Clin Pharmacol (1975) 0.92
The semitendinosus tendon regenerates after resection: a morphologic and MRI analysis in 6 patients after resection for anterior cruciate ligament reconstruction. Acta Orthop Scand (2001) 0.92
The diagnostic reliability of magnetically evoked motor potentials in multiple sclerosis. Neurology (1992) 0.91
Semitendinosus tendon regeneration after harvesting for ACL reconstruction. A prospective MRI study. Knee Surg Sports Traumatol Arthrosc (1999) 0.91
Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. Eur Heart J (1998) 0.91
Wheelchair seating intervention. Results from a client-centred approach. Disabil Rehabil (2001) 0.90
Gastric acid secretion in the totally isolated, vascularly perfused rat stomach. A selective muscarinic-1 agent does, whereas gastrin does not, augment maximal histamine-stimulated acid secretion. Scand J Gastroenterol (1987) 0.89
New generation cardiac troponin I assay for the access immunoassay system. Clin Chem (2001) 0.89
The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate. Scand J Urol Nephrol (1982) 0.89
Plasma fibrinogen in unstable coronary artery disease. Scand J Clin Lab Invest (1989) 0.89
Evidence for diabetic encephalopathy. Diabet Med (1991) 0.88
Effect of omeprazole on gastric secretion in H+,K+-ATPase and in pepsinogen-rich cell fractions from rabbit gastric mucosa. Biochem Pharmacol (1984) 0.88
Nicotine attenuates the ventilatory response to hypoxia in the developing lamb. Pediatr Res (1995) 0.88
Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipids. Acta Endocrinol (Copenh) (1977) 0.88
Pharmacology and toxicology of omeprazole--with special reference to the effects on the gastric mucosa. Scand J Gastroenterol Suppl (1986) 0.87
Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance. Diabetologia (1998) 0.87
ST-segment monitoring with continuous 12-lead ECG improves early risk stratification in patients with chest pain and ECG nondiagnostic of acute myocardial infarction. J Am Coll Cardiol (1999) 0.87
Regulation of circulating leptin in humans. Endocrine (1997) 0.87